With Humira declining, AbbVie is heavily reliant on the rapid growth of Skyrizi (+29%) and Rinvoq (+20%). This intense focus on scaling these key products creates demand for supply chain management, marketing automation, sales enablement, and data analytics to support their 'strong market share uptake' and continued expansion.
Filing excerpt
Net revenues for Skyrizi increased 29% for the three months ended March 31, 2026 primarily driven by continued strong market share uptake as well as market growth across all indications.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qmarketExpansionGet every 10-Q signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/fb00dcba-b50a-4ef0-8f88-2f96d3134ff9 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "fb00dcba-b50a-4ef0-8f88-2f96d3134ff9",
"signal_type": "sec-10q",
"signal_subtype": "marketExpansion",
"detected_at": "2026-05-12T09:24:56.954+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "With Humira declining, AbbVie is heavily reliant on the rapid growth of Skyrizi (+29%) and Rinvoq (+20%). This intense focus on scaling these key products creates demand for supply chain management, marketing automation, sales enablement, and data analytics to support their 'strong market share uptake' and continued expansion.",
"metrics": {
"pct": 0.29,
"timeframe": "current_quarter",
"pct_context": "Skyrizi net revenue increase YoY"
},
"summary": "Skyrizi and Rinvoq sales surge 29% and 20% as AbbVie's new growth drivers",
"excerpts": "Net revenues for Skyrizi increased 29% for the three months ended March 31, 2026 primarily driven by continued strong market share uptake as well as market growth across all indications.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/abbv-20260331.htm",
"filing_date": "2026-05-08",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Scaling infrastructure needed",
"signal_category": "market"
}
}
curl https://signals.autobound.ai/v1/signals/fb00dcba-b50a-4ef0-8f88-2f96d3134ff9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.